Clinical View Podcasts Brought to you by GE HealthCare

How widespread are enhanced recovery principles? Are patients living the drinking, eating and mobilizing early on and so “living the (drink, eat, mobilize) dream?”.

This podcast was recorded by TopMedTalk. If you would like to listen to this podcast from the TopMedTalk platform click here

The ECG provides critical information that assists in establishing the diagnosis of acute coronary syndrome and determining the treatment strategy. In acute coronary syndrome, common ECG abnormalities include T-wave tenting or inversion, ST-segment elevation or depression (including J-point elevation in multiple leads), and pathologic Q waves. ECG risk stratification allows appropriate referral of patients to a chest pain center or, even, to a catheterization laboratory. 

Thus, in this podcast Dr. Cosentino aims at improving your confidence in the interpretation of ECG during a suspected or confirmed acute coronary syndrome. A systematic approach to ECG analysis is essential for identifying an early and appropriate management for patients with acute coronary syndrome. 

This podcast is ideal for those required to interpret ECGs during suspected or confirmed acute coronary syndrome within their clinical role and who wish to quickly develop a reliable method for ECG interpretation in this clinical setting.

Continuous ECG monitoring is currently applied in a variety of critical and non-critical care hospital settings. While early monitoring focused on heart rate measurement and fatal arrhythmia detection in acutely-ill cardiac patients, current ECG monitoring has expanded to include diagnoses of complex arrhythmias, acute myocardial ischemia, and (pharmacologically-induced) prolonged QT intervals in real time in several areas of the hospital. Thus, the clinical recommendations for using continuous ECG monitoring are a critical issue in daily clinical practice. 

In this podcast, Dr. Nicola Cosentino provides a quick update for recommendations for continuous ECG monitoring of hospitalized patients, addressing its appropriate use in different clinical settings. In particular, a simple, but systematic, approach focusing on how to prioritize when dealing with continuous ECG monitoring is here provided.

ECG monitoring was initially employed in coronary care units during the 1950s and 1960s. Today, it is more broadly applied in a variety of critical and non-critical care hospital settings. Moreover, while early monitoring focused on heart rate measurement and fatal arrhythmia detection in acutely-ill cardiac patients, current ECG monitoring has expanded to include diagnoses of complex arrhythmias, acute myocardial ischemia, and (pharmacologically-induced) prolonged QT intervals in real time also in non-cardiac areas of the hospital. 

Thus, cardiac monitoring is a useful, noninvasive diagnostic tool that assists clinicians not only in detecting life-threatening arrhythmias but also in early identification patients who need to be urgently treated due to the ongoing clinical deterioration. 

The purpose of this podcast is to provide a quick review for continuous ECG monitoring of patients hospitalized in non-cardiac areas, addressing its appropriate use and the expected clinical benefits.

COVID-19 infection may have a negative impact on the cardiovascular system by potentially causing myocardial damage, vascular inflammation, and myocardial infarction. The presence of myocardial injury is a poor prognostic sign. 

Electrocardiogram, a simple bedside diagnostic test with high prognostic value, and continuous ECG monitoring can be employed to assess early cardiovascular involvement in such patients and to rapidly detect life-threatening arrhythmias and/or impending clinical deterioration. 

In this podcast, we will discuss the central role of 12-lead ECG and continuous ECG monitoring in COVID-19 patients. In particular, this podcast will provide practical insights and clinical protocols that can assist physicians in managing high-risk COVID-19 patients.

COVID-19 infection is a multisystem disease not restricted to the lungs. It may have a negative impact on the cardiovascular system by potentially causing myocardial damage, vascular inflammation, and myocardial infarction. The presence of myocardial injury is a poor prognostic sign. Electrocardiogram, a simple bedside diagnostic test with high prognostic value, can be employed to assess early cardiovascular involvement in such patients. Various abnormalities in ECG like QRS complex and QTc interval prolongation, ST-T changes, arrhythmia, and conduction defects have been reported in COVID-19. 

In this podcast, cardiology intensivist Dr. Nicola Cosentino will discuss the central role of ECG in the setting of COVID-19 patients. In particular, this podcast will highlight the impact of COVID-19 on ECG findings and on the risk of acute and life-threatening rhythm disorders.

Most patients who die after surgery are dying on the wards. In fact, EuSOS study looked at over 46,000 patients from just under 500 hospitals in 28 countries and found out that 73% of patients who died were not admitted to a critical care unit.

Discover how these outcomes may be improved with Frederic Michard in this Clinical View podcast.

This podcast was recorded at ASA 2018 in San Francisco by TopMedTalk. If you would like to listen to this podcast from the TopMedTalk platform click here.

Listen to Bernd Saugel at Euroanesthesia 2022 as he reviews several topics, including blood pressure, what an appropriate target is for a perioperative practitioner and the post-op period and transition of care.

This podcast was recorded by TopMedTalk in Milano, Italy at Euroanesthesia 2022. Click here if you would like to listen to it from the TopMedTalk platform.

Intraoperative mortality is now so rare that it's hard to quantify. In fact, if the 30 days after surgery were considered a disease, it would be the third leading cause of death in the United States.

About two percent of inpatients over the age of 45 die within a month after surgery.

Discover more about postoperative mortality and continuous monitoring with Frederic Michard and Dan Sessler at Euroanesthesia 2022.

In this podcast, John "JW" Beard, Chief Medical Officer of GE Patient Care solutions, GE Healthcare, Eric Ruedinger, General Manager for Anesthesia and Respiratory Care, Patient Care Solutions, GE Healthcare and Guy Dear, Pediatric Anesthesiologist at Duke University Hospital discuss advances in low-flow anesthesia.

Et Control in the USA is approved for patients 18 years of age and older.